VENTYX BIOSCIENCES INC (VTYX) Stock Fundamental Analysis

NASDAQ:VTYX • US92332V1070

13.965 USD
-0.01 (-0.04%)
Last: Feb 23, 2026, 10:22 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to VTYX. VTYX was compared to 192 industry peers in the Pharmaceuticals industry. While VTYX has a great health rating, there are worries on its profitability. VTYX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year VTYX has reported negative net income.
  • VTYX had a negative operating cash flow in the past year.
  • VTYX had negative earnings in each of the past 5 years.
  • In the past 5 years VTYX always reported negative operating cash flow.
VTYX Yearly Net Income VS EBIT VS OCF VS FCFVTYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

  • With a Return On Assets value of -50.41%, VTYX is not doing good in the industry: 61.98% of the companies in the same industry are doing better.
  • VTYX's Return On Equity of -55.71% is in line compared to the rest of the industry. VTYX outperforms 51.04% of its industry peers.
Industry RankSector Rank
ROA -50.41%
ROE -55.71%
ROIC N/A
ROA(3y)-49.18%
ROA(5y)-2852.36%
ROE(3y)-54.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VTYX Yearly ROA, ROE, ROICVTYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5K -10K

1.3 Margins

  • VTYX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VTYX Yearly Profit, Operating, Gross MarginsVTYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, VTYX has more shares outstanding
  • VTYX has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for VTYX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VTYX Yearly Shares OutstandingVTYX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
VTYX Yearly Total Debt VS Total AssetsVTYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 25.00 indicates that VTYX is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 25.00, VTYX belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
  • VTYX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25
ROIC/WACCN/A
WACCN/A
VTYX Yearly LT Debt VS Equity VS FCFVTYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 17.86 indicates that VTYX has no problem at all paying its short term obligations.
  • The Current ratio of VTYX (17.86) is better than 89.58% of its industry peers.
  • VTYX has a Quick Ratio of 17.86. This indicates that VTYX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of VTYX (17.86) is better than 89.58% of its industry peers.
Industry RankSector Rank
Current Ratio 17.86
Quick Ratio 17.86
VTYX Yearly Current Assets VS Current LiabilitesVTYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • VTYX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.44%, which is quite impressive.
EPS 1Y (TTM)36.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, VTYX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.83% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25.5%
EPS Next 2Y5.91%
EPS Next 3Y1.01%
EPS Next 5Y9.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VTYX Yearly Revenue VS EstimatesVTYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 500M 1B
VTYX Yearly EPS VS EstimatesVTYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VTYX. In the last year negative earnings were reported.
  • Also next year VTYX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VTYX Price Earnings VS Forward Price EarningsVTYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VTYX Per share dataVTYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.91%
EPS Next 3Y1.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • VTYX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VENTYX BIOSCIENCES INC

NASDAQ:VTYX (2/23/2026, 10:22:31 AM)

13.965

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners68.35%
Inst Owner Change19.9%
Ins Owners4.24%
Ins Owner Change0.61%
Market Cap1.00B
Revenue(TTM)N/A
Net Income(TTM)-106.61M
Analysts70.67
Price Target13.64 (-2.33%)
Short Float %6.27%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.41%
Min EPS beat(2)20.73%
Max EPS beat(2)30.09%
EPS beat(4)4
Avg EPS beat(4)24.4%
Min EPS beat(4)20.73%
Max EPS beat(4)30.09%
EPS beat(8)8
Avg EPS beat(8)19.04%
EPS beat(12)9
Avg EPS beat(12)10.5%
EPS beat(16)12
Avg EPS beat(16)11.87%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.67%
PT rev (3m)-2.47%
EPS NQ rev (1m)1.77%
EPS NQ rev (3m)0.34%
EPS NY rev (1m)0.45%
EPS NY rev (3m)13.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.24
P/tB 5.24
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS0
BVpS2.67
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -50.41%
ROE -55.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49.18%
ROA(5y)-2852.36%
ROE(3y)-54.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -20.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.86
Quick Ratio 17.86
Altman-Z 25
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)216.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36%
EPS Next Y25.5%
EPS Next 2Y5.91%
EPS Next 3Y1.01%
EPS Next 5Y9.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.18%
EBIT Next 3Y9.01%
EBIT Next 5YN/A
FCF growth 1Y45.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.88%
OCF growth 3YN/A
OCF growth 5YN/A

VENTYX BIOSCIENCES INC / VTYX FAQ

What is the ChartMill fundamental rating of VENTYX BIOSCIENCES INC (VTYX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to VTYX.


What is the valuation status for VTYX stock?

ChartMill assigns a valuation rating of 0 / 10 to VENTYX BIOSCIENCES INC (VTYX). This can be considered as Overvalued.


How profitable is VENTYX BIOSCIENCES INC (VTYX) stock?

VENTYX BIOSCIENCES INC (VTYX) has a profitability rating of 0 / 10.


How financially healthy is VENTYX BIOSCIENCES INC?

The financial health rating of VENTYX BIOSCIENCES INC (VTYX) is 8 / 10.